Methyl Carbamate

Methyl Carbamate

SCHEMBL6828080

COC(N)=O.CONCCc1c[nH]c2ccccc12

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.61
▸ KMT2A Q03164 4/20 0.61
▸ LMNA P02545 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ PKM P14618 1/20 0.61
▸ TSHR P16473 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ BLM P54132 1/20 0.61
▸ MTNR1A P48039 2/20 0.57
▸ HTR2A P28223 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ HTR1A P08908 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ NPC1 O15118 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ POLB P06746 1/20 0.57
▸ MMP9 P14780 1/20 0.55
▸ AANAT Q16613 1/20 0.55
▸ FAAH O00519 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL678380 0.90 HTR2A (0.69) MEN1KMT2ALMNACYP1A2PKM
Hydrochloric Acid SCHEMBL5833228 0.89 HTR2A (0.67) MEN1KMT2ALMNACYP1A2PKM
SCHEMBL28875080 0.86 MEN1 (0.60) MEN1KMT2ALMNACYP1A2PKM
Tryptamine SCHEMBL9699478 0.85 CYP1A2 (0.71) MEN1KMT2ALMNACYP1A2PKM
SCHEMBL9559245 0.81 MEN1 (0.68) MEN1KMT2ALMNACYP1A2PKM
SCHEMBL20927525 0.80 MEN1 (0.74) MEN1KMT2ALMNACYP1A2PKM
SCHEMBL627038 0.79 MEN1 (0.74) MEN1KMT2ALMNACYP1A2PKM
SCHEMBL9705533 0.79 MEN1 (0.65) MEN1KMT2ALMNACYP1A2PKM
SCHEMBL28242499 0.79 HTR2A (0.64) MEN1KMT2ALMNACYP1A2PKM
SCHEMBL29634969 0.78 MAPT (0.72) MEN1KMT2ALMNACYP1A2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004075847-A2 METHODS AND COMPOUNDS FOR THE TREATMENT OF Aß­ ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS MESSAGE PHARMACEUTICALS, INC. (US) 2004-09-10 — — WO disclosed
Send feedback